Integra LifeSciences Holdings Corporation (IART) Insider Trading

Last 12 months

Insiders bought $102k on the open market and sold nothing.

Net open-market

+$102k

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Nov 2025

Nov 5, 2025

Get an email when IART's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 5, 2025	Jeffrey A Graves Director	Bought	9,000	$11.35	$102k	28%	Form 4
Dec 3, 2024	Eric Schwartz EVP, Chief Legal Officer & Sec	SoldNo plan	4,070	$24.60	$100k	6.4%	Form 4
Dec 2, 2024	Michael J. McBreen EVP & President, CSS	SoldNo plan	1,700	$24.16	$41k	2.9%	Form 4

Nov 5, 2025
Jeffrey A Graves
Director · bought 9,000 at $11.35
$102k
28% of stake
Dec 3, 2024No plan
Eric Schwartz
EVP, Chief Legal Officer & Sec · sold 4,070 at $24.60
$100k
6.4% of stake
Dec 2, 2024No plan
Michael J. McBreen
EVP & President, CSS · sold 1,700 at $24.16
$41k
2.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IART, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

MMSIMerit Medical Systems, Inc.

PENPenumbra Inc.

HAEHaemonetics Corporation

ICUIIcu Medical Inc.

TNDMTandem Diabetes Care Inc.

EMBCEmbecta Corp.

INSPInspire Medical Systems, Inc.

OFIXOrthofix Medical Inc.

Spot a number that looks wrong? Check it in IART's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IART

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.